ADC Therapeutics Ltd (ADCT)
NYSE:ADCT
US Market
Holding ADCT?
Track your performance easily

ADC Therapeutics (ADCT) Financial Statements

301 Followers

ADC Therapeutics Financial Overview

ADC Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.399; its P/E ratio is -1.22; ADC Therapeutics is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 18.46M$ 17.41M-$ 76.32M$ 17.29M
Gross Profit$ 18.02M$ 17.03M-$ 75.03M$ 15.03M
EBIT$ -30.75M$ -23.66M-$ -39.96M$ -56.52M
EBITDA$ -22.78M$ -15.90M-$ -39.39M$ -55.93M
Net Income Common Stockholders$ -43.13M$ -36.54M-$ -50.61M$ -64.37M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 274.30M$ 300.10M$ 31.15M$ 380.86M$ 376.78M
Total Assets$ 349.08M$ 371.78M$ 529.17M$ 531.76M$ 520.46M
Total Debt$ 123.08M$ 123.01M$ 7.66M$ 116.66M$ 103.32M
Net Debt$ -151.22M$ -177.09M$ -23.49M$ -264.20M$ -273.46M
Total Liabilities$ 521.02M$ 503.48M$ 440.44M$ 426.98M$ 405.12M
Stockholders Equity$ -171.95M$ -131.67M$ -73.91M$ 104.78M$ 115.35M
Cash Flow-
Free Cash Flow$ -25.26M$ -32.88M-$ 1.94M$ -53.82M
Operating Cash Flow$ -25.04M$ -32.84M-$ 2.19M$ -53.01M
Investing Cash Flow$ -216.00K$ -30.00K-$ -254.00K$ -689.00K
Financing Cash Flow$ -879.00K$ 98.70M-$ 2.37M$ -252.00K
Currency in USD

ADC Therapeutics Earnings and Revenue History

ADC Therapeutics Debt to Assets

ADC Therapeutics Cash Flow

ADC Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis